Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
2.
Br Dent J ; 202(11): 643, 2007 Jun 09.
Article in English | MEDLINE | ID: mdl-17595603
4.
Aliment Pharmacol Ther ; 20(6): 645-55, 2004 Sep 15.
Article in English | MEDLINE | ID: mdl-15352913

ABSTRACT

BACKGROUND: Non-steroidal anti-inflammatory drugs use may protect against development of oesophageal adenocarcinoma. AIM: To define the consequences of non-steroidal anti-inflammatory drugs use in patients with Barrett's oesophagus. METHODS: Records of all Barrett's oesophagus/oesophageal adenocarcinoma patients examined in Blackpool-Wyre-Fylde area were reviewed. All surviving patients completed validated questionnaires. RESULTS: Use of non-steroidal anti-inflammatory drugs of any type and at any frequency was more prevalent in Barrett's oesophagus patients [147 (38%) Barrett's oesophagus vs. 30 (26%) oesophageal adenocarcinoma, P = 0.02]. Daily use of non-steroidal anti-inflammatory drugs was more prevalent in Barrett's oesophagus patients [88 (23%) Barrett's oesophagus vs. 14 (12%) oesophageal adenocarcinoma, P = 0.02], due to more prevalent consumption of non-aspirin non-steroidal anti-inflammatory drugs [48 (13%) Barrett's oesophagus vs. four (4%) oesophageal adenocarcinoma, P = 0.009]. There was no difference between the two groups in usage of either daily low-dose aspirin or of occasional non-steroidal anti-inflammatory drugs. In logistic regression analysis any use of non-steroidal anti-inflammatory drugs [odds ratio (OR) = 0571 (95% CI: 0.359-0.909), P = 0.018] and daily use of non-aspirin non-steroidal anti-inflammatory drugs [OR = 0.297 (95% CI: 0.097-0.911), P = 0.034] were significant protective factors. Non-steroidal anti-inflammatory drugs use did not affect the survival of oesophageal adenocarcinoma patients. Oesophageal adenocarcinoma and Barrett's oesophagus consuming non-steroidal anti-inflammatory drugs did not differ in upper gastrointestinal bleeding [26 (15%) non-steroidal anti-inflammatory drugs consumers vs. 29 (9%) non-consumers, P = 0.08], oesophageal ulcers [31 (18%) non-steroidal anti-inflammatory drug consumers vs. 49 (15%) non-consumers, P = 0.43] or stricturing [19 (11%) non-steroidal anti-inflammatory drug consumers vs. 41 (13%) non-consumers, P = 0.58]. CONCLUSIONS: (i) Daily use of non-steroidal anti-inflammatory drugs is more prevalent in Barrett's oesophagus than oesophageal adenocarcinoma patients, because of a more prevalent use of non-aspirin non-steroidal anti-inflammatory drugs. (ii) Use of non-steroidal anti-inflammatory drugs in Barrett's oesophagus patients is safe if acid suppression is adequate.


Subject(s)
Adenocarcinoma/prevention & control , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Barrett Esophagus/drug therapy , Esophageal Neoplasms/prevention & control , Adenocarcinoma/pathology , Aged , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Barrett Esophagus/pathology , Biopsy/methods , Esophageal Neoplasms/pathology , Esophagus/pathology , Female , Gastrointestinal Hemorrhage/chemically induced , Humans , Male , Peptic Ulcer/chemically induced , Survival Analysis
7.
Dig Liver Dis ; 35(4): 275-82, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12801040

ABSTRACT

BACKGROUND: One of the available treatments for unresectable oesophagogastric malignancies is the insertion of metal stents. AIMS: We evaluated prospectively 147 patients suffering from malignant dysphagia and/or fistula, after inserting a self-expandable metal stent. PATIENTS AND METHODS: The study included 147 patients (87 males, mean age 73 years). Dysphagia before and after stent placement was scored. Patients were divided in two groups according to dysphagia grade: group A (grade 0, 1) and group B (grades 2, 3, 4). Three types of stents were used: the Ultraflex stent (covered and uncovered) and the Flamingo one (covered). The total number of self-expandable metal stents placed was 183. A total of 92 of them were inserted following the combined endoscopic and fluoroscopic approach (42 by injecting lipiodol), while 91 were placed under endoscopic control only. Early and late complications were evaluated. RESULTS: Mean dysphagia score in group A, 1 day and 1 month after the procedure, was slightly reduced from 0.8 to 0.5/0.6 (p=NS), respectively. However, there was a statistically significant improvement (p<0.001) of mean dysphagia score in group B, from 2.4 initially to 1.1/1.4. Early complications occurred in 37 cases, late ones in 51. According to severity, minor complications occurred in 24 patients, major in 42, while life-threatening ones in 22. Survival ranged from 1 to 611 days and 1-week mortality was 9%. Stent-related death occurred in six patients. CONCLUSIONS: All kinds of endoscopic methods used for stenting in the present study were easy to perform even on an out-patient basis. Insertion of self-expandable metal stents is effective in patients with dysphagia scores > or = 2. It might not clinically improve patients with dysphagia score <2, so selection of patients for stenting is essential to avoid unnecessary procedures. Moreover, their high cost, high complication rates and low overall survival may improve following better selection criteria.


Subject(s)
Deglutition Disorders/therapy , Esophageal Fistula/therapy , Palliative Care/methods , Stents , Adenocarcinoma/complications , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/complications , Deglutition Disorders/classification , Deglutition Disorders/etiology , Esophageal Fistula/etiology , Esophageal Neoplasms/complications , Female , Humans , Male , Middle Aged , Prospective Studies , Stents/adverse effects , Survival Analysis
8.
J Clin Child Psychol ; 30(1): 48-58, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11294077

ABSTRACT

Highlights the desirability of using a theoretical framework for guiding the design and evaluation of therapeutic interventions for children with attention deficit hyperactivity disorder (ADHD). A general conceptual model is introduced and used to evaluate ADHD treatment outcome research. Treatments designed to target the substrate level (pharmacological interventions) result in broad, robust improvement in both core and peripheral areas of functioning. Those targeting hypothesized core features of the disorder (i.e., attention, impulsivity-hyperactivity) produce corresponding improvement in core and peripheral outcome measures with the exception of studies employing cognitive-behavior therapy. Those targeting peripheral features of the disorder effect change only in corresponding peripheral areas of functioning. Implications for clinical practice are discussed, and an alternative conceptual model of ADHD is introduced and compared with existing models.


Subject(s)
Attention Deficit Disorder with Hyperactivity/psychology , Attention Deficit Disorder with Hyperactivity/therapy , Central Nervous System Stimulants/therapeutic use , Models, Psychological , Psychotherapy/methods , Attention , Behavior Therapy , Child , Cognitive Behavioral Therapy , Humans , Impulsive Behavior , Socialization
9.
Radiology ; 218(3): 873-80, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11230669

ABSTRACT

PURPOSE: To prospectively compare full-field digital mammography (FFDM) with screen-film mammography (SFM) for cancer detection in a screening population. MATERIALS AND METHODS: At two institutions, 4,945 FFDM examinations were performed in women aged 40 years and older presenting for SFM. Two views of each breast were acquired with each modality. SFM and FFDM images were interpreted independently. Findings detected with either SFM or FFDM were evaluated with additional imaging and, if warranted, biopsy. RESULTS: Patients in the study underwent 152 biopsies, which resulted in the diagnosis of 35 breast cancers. Twenty-two cancers were detected with SFM and 21 with FFDM. Four were interval cancers that became palpable within 1 year of screening and were considered false-negative findings with both modalities. The difference in cancer detection rate was not significant. FFDM had a significantly lower recall rate (11.5%; 568 of 4,945) than SFM (13.8%; 685 of 4,945) (P <.001, McNemar chi(2) model; P <.03, generalized estimating equations model). The positive biopsy rate for findings detected with FFDM (30%; 21 of 69) was higher than that for findings detected with SFM (19%; 22 of 114), but this difference was not significant. CONCLUSION: No difference in cancer detection rate has yet been observed between FFDM and SFM. FFDM has so far led to fewer recalls than SFM.


Subject(s)
Breast Neoplasms/diagnostic imaging , Mammography/methods , Radiographic Image Enhancement/methods , Biopsy , Breast Neoplasms/pathology , False Negative Reactions , Female , Follow-Up Studies , Humans , Image Interpretation, Computer-Assisted , Middle Aged , Predictive Value of Tests , ROC Curve , Sensitivity and Specificity
11.
J Clin Child Psychol ; 29(4): 555-68, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11126633

ABSTRACT

Reviews the usefulness of clinic-based and laboratory-based instruments and paradigms for diagnosing attention deficit hyperactivity disorder (ADHD) and monitoring treatment effects. Extant literature examining the performance of normal children and those with ADHD on an extensive range of neurocognitive tests, tasks, and experimental paradigms indicates that particular types of instruments may be more reliable than others with respect to detecting between-group differences. We review task parameters that may distinguish the more reliable from less reliable instruments. The value of clinic-based and laboratory-based instruments for monitoring treatment response in children with ADHD is questionable when evaluated in the context of ecologically relevant variables such as classroom behavior and academic functioning. We present a general conceptual model to highlight conceptual issues relevant to designing clinic-based and laboratory-based instruments for the purposes of diagnosing and monitoring treatment effects in children with ADHD. Application of the model to currently conceptualized core variables indicates that attention and impulsivity-hyperactivity may represent correlative rather than core features of the disorder. We discuss implications of these findings for designing the next generation of clinic-based and laboratory-based instruments.


Subject(s)
Attention Deficit Disorder with Hyperactivity/diagnosis , Child Behavior/classification , Child , Child Psychiatry/methods , Humans , Memory , Neuropsychological Tests , Observer Variation , Peer Group , Psychometrics , Task Performance and Analysis
13.
Eur J Gastroenterol Hepatol ; 9(9): 913-5, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9355793

ABSTRACT

A case is presented of caecal tuberculosis coexisting with adenocarcinoma at the same site, unusually presenting as a right iliac fossa abscess. The relevant literature on 61 previously reported patients with coexisting tuberculosis and colonic carcinoma is reviewed. The patient was 81-years-old, female with a tender swelling in the right iliac fossa. Following examination by ultrasound, laparotomy was undertaken which revealed a large abscess cavity contaminated by Mycobacterium tuberculosis. Although anti-tuberculosis treatment was given, there was a persistent purulent discharge from the wound, so a new ultrasound, computed tomography scan and barium enema were arranged. These could not clearly differentiate between ileocaecal tuberculosis and carcinoma. A second laparotomy showed that there was an underlying adenocarcinoma. Although rare, the coexistence of colonic tuberculosis with carcinoma should be seriously considered especially in patients who fail to respond to anti-tuberculosis treatment. A definitive diagnosis can be established only by histological examination.


Subject(s)
Adenocarcinoma/complications , Colonic Diseases/complications , Colonic Neoplasms/complications , Tuberculosis, Gastrointestinal/complications , Adenocarcinoma/diagnostic imaging , Aged , Aged, 80 and over , Barium Sulfate , Colonic Diseases/diagnostic imaging , Colonic Neoplasms/diagnostic imaging , Enema , Fatal Outcome , Female , Humans , Tomography, X-Ray Computed , Tuberculosis, Gastrointestinal/diagnostic imaging
15.
Eur J Gastroenterol Hepatol ; 8(11): 1121-4, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8944377

ABSTRACT

This report concerns four patients in a district general hospital who died from malignant liver tumours associated with Thorotrast (thorium dioxide) deposits in the liver. Three were known to have had diagnostic angiographic studies performed 36 to 43 years previously using Thorotrast as the contrast agent. In the fourth case no previous relevant information could be obtained. There were two men and one woman with hepatocellular carcinoma and one woman with cholangiocarcinoma. In one of the hepatoma cases there was associated hypercalcaemia of malignancy. Reported latency intervals suggest that cases of Thorotrast-related hepatic malignancy may present up to the second decade of the twenty-first century.


Subject(s)
Bile Duct Neoplasms/chemically induced , Carcinogens/adverse effects , Carcinoma, Hepatocellular/chemically induced , Cholangiocarcinoma/chemically induced , Liver Neoplasms/chemically induced , Thorium Dioxide/adverse effects , Aged , Aged, 80 and over , Bile Duct Neoplasms/pathology , Bile Duct Neoplasms/physiopathology , Carcinoma, Hepatocellular/pathology , Carcinoma, Hepatocellular/physiopathology , Cholangiocarcinoma/pathology , Cholangiocarcinoma/physiopathology , Common Bile Duct , Fatal Outcome , Female , Humans , Liver Neoplasms/pathology , Liver Neoplasms/physiopathology , Male , Middle Aged , Risk Factors , Time Factors
16.
Behav Modif ; 20(4): 428-30, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8875814

ABSTRACT

The effectiveness of four doses (5-mg, 10-mg, 15-mg, 20-mg) of methylphenidate (MPH) and attentional training (AT) were evaluated using neurocognitive instruments (Continuous Performance Test; Matching Unfamiliar Figures Test), narrow- and broad-band rating scales in the context of a double-blind, placebo-control, within-subject reversal design for dizygotic twin girls with Attention-Deficit/Hyperactivity Disorder (ADHD). Both interventions proved effective for improving neurocognitive test performance and behavior, although broad-band ratings revealed dose-response curves different from those obtained from the neurocognitive tests. Implications for clinical management of girls with ADHD are discussed.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Behavior Therapy , Central Nervous System Stimulants/administration & dosage , Diseases in Twins/genetics , Learning Disabilities/genetics , Methylphenidate/administration & dosage , Attention/drug effects , Attention Deficit Disorder with Hyperactivity/psychology , Attention Deficit Disorder with Hyperactivity/therapy , Combined Modality Therapy , Dose-Response Relationship, Drug , Double-Blind Method , Drug Administration Schedule , Female , Humans , Learning Disabilities/therapy , Motor Activity/drug effects , Neuropsychological Tests , Personality Assessment , Twins, Dizygotic/genetics , Twins, Dizygotic/psychology
18.
Gut ; 37(5): 731-3, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8549954

ABSTRACT

Linear IgA dermatosis is a malignancy associated rare bullous disorder similar to dermatitis herpetiformis. Linear IgA dermatosis differs from dermatitis herpetiformis in that the IgA deposits in the epidermal basement membrane are linear rather than granular. A patient is presented with coeliac disease who presented with linear IgA dermatosis and anaemia caused by chronic low grade B cell lymphoma.


Subject(s)
Celiac Disease/complications , Lymphoma, B-Cell/complications , Skin Diseases, Vesiculobullous/complications , Aged , Celiac Disease/diet therapy , Fatal Outcome , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...